Cargando…

Evaluation of the public health impacts of traffic congestion: a health risk assessment

BACKGROUND: Traffic congestion is a significant issue in urban areas in the United States and around the world. Previous analyses have estimated the economic costs of congestion, related to fuel and time wasted, but few have quantified the public health impacts or determined how these impacts compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Jonathan I, Buonocore, Jonathan J, von Stackelberg, Katherine
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987789/
https://www.ncbi.nlm.nih.gov/pubmed/20979626
http://dx.doi.org/10.1186/1476-069X-9-65
_version_ 1782192154084376576
author Levy, Jonathan I
Buonocore, Jonathan J
von Stackelberg, Katherine
author_facet Levy, Jonathan I
Buonocore, Jonathan J
von Stackelberg, Katherine
author_sort Levy, Jonathan I
collection PubMed
description BACKGROUND: Traffic congestion is a significant issue in urban areas in the United States and around the world. Previous analyses have estimated the economic costs of congestion, related to fuel and time wasted, but few have quantified the public health impacts or determined how these impacts compare in magnitude to the economic costs. Moreover, the relative magnitudes of economic and public health impacts of congestion would be expected to vary significantly across urban areas, as a function of road infrastructure, population density, and atmospheric conditions influencing pollutant formation, but this variability has not been explored. METHODS: In this study, we evaluate the public health impacts of ambient exposures to fine particulate matter (PM(2.5)) concentrations associated with a business-as-usual scenario of predicted traffic congestion. We evaluate 83 individual urban areas using traffic demand models to estimate the degree of congestion in each area from 2000 to 2030. We link traffic volume and speed data with the MOBILE6 model to characterize emissions of PM(2.5 )and particle precursors attributable to congestion, and we use a source-receptor matrix to evaluate the impact of these emissions on ambient PM(2.5 )concentrations. Marginal concentration changes are related to a concentration-response function for mortality, with a value of statistical life approach used to monetize the impacts. RESULTS: We estimate that the monetized value of PM(2.5)-related mortality attributable to congestion in these 83 cities in 2000 was approximately $31 billion (2007 dollars), as compared with a value of time and fuel wasted of $60 billion. In future years, the economic impacts grow (to over $100 billion in 2030) while the public health impacts decrease to $13 billion in 2020 before increasing to $17 billion in 2030, given increasing population and congestion but lower emissions per vehicle. Across cities and years, the public health impacts range from more than an order of magnitude less to in excess of the economic impacts. CONCLUSIONS: Our analyses indicate that the public health impacts of congestion may be significant enough in magnitude, at least in some urban areas, to be considered in future evaluations of the benefits of policies to mitigate congestion.
format Text
id pubmed-2987789
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29877892010-11-23 Evaluation of the public health impacts of traffic congestion: a health risk assessment Levy, Jonathan I Buonocore, Jonathan J von Stackelberg, Katherine Environ Health Research BACKGROUND: Traffic congestion is a significant issue in urban areas in the United States and around the world. Previous analyses have estimated the economic costs of congestion, related to fuel and time wasted, but few have quantified the public health impacts or determined how these impacts compare in magnitude to the economic costs. Moreover, the relative magnitudes of economic and public health impacts of congestion would be expected to vary significantly across urban areas, as a function of road infrastructure, population density, and atmospheric conditions influencing pollutant formation, but this variability has not been explored. METHODS: In this study, we evaluate the public health impacts of ambient exposures to fine particulate matter (PM(2.5)) concentrations associated with a business-as-usual scenario of predicted traffic congestion. We evaluate 83 individual urban areas using traffic demand models to estimate the degree of congestion in each area from 2000 to 2030. We link traffic volume and speed data with the MOBILE6 model to characterize emissions of PM(2.5 )and particle precursors attributable to congestion, and we use a source-receptor matrix to evaluate the impact of these emissions on ambient PM(2.5 )concentrations. Marginal concentration changes are related to a concentration-response function for mortality, with a value of statistical life approach used to monetize the impacts. RESULTS: We estimate that the monetized value of PM(2.5)-related mortality attributable to congestion in these 83 cities in 2000 was approximately $31 billion (2007 dollars), as compared with a value of time and fuel wasted of $60 billion. In future years, the economic impacts grow (to over $100 billion in 2030) while the public health impacts decrease to $13 billion in 2020 before increasing to $17 billion in 2030, given increasing population and congestion but lower emissions per vehicle. Across cities and years, the public health impacts range from more than an order of magnitude less to in excess of the economic impacts. CONCLUSIONS: Our analyses indicate that the public health impacts of congestion may be significant enough in magnitude, at least in some urban areas, to be considered in future evaluations of the benefits of policies to mitigate congestion. BioMed Central 2010-10-27 /pmc/articles/PMC2987789/ /pubmed/20979626 http://dx.doi.org/10.1186/1476-069X-9-65 Text en Copyright ©2010 Levy et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Levy, Jonathan I
Buonocore, Jonathan J
von Stackelberg, Katherine
Evaluation of the public health impacts of traffic congestion: a health risk assessment
title Evaluation of the public health impacts of traffic congestion: a health risk assessment
title_full Evaluation of the public health impacts of traffic congestion: a health risk assessment
title_fullStr Evaluation of the public health impacts of traffic congestion: a health risk assessment
title_full_unstemmed Evaluation of the public health impacts of traffic congestion: a health risk assessment
title_short Evaluation of the public health impacts of traffic congestion: a health risk assessment
title_sort evaluation of the public health impacts of traffic congestion: a health risk assessment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987789/
https://www.ncbi.nlm.nih.gov/pubmed/20979626
http://dx.doi.org/10.1186/1476-069X-9-65
work_keys_str_mv AT levyjonathani evaluationofthepublichealthimpactsoftrafficcongestionahealthriskassessment
AT buonocorejonathanj evaluationofthepublichealthimpactsoftrafficcongestionahealthriskassessment
AT vonstackelbergkatherine evaluationofthepublichealthimpactsoftrafficcongestionahealthriskassessment